A precedential ruling holds cancer treatment dosing claims invalid under Section 112(a), erasing a nine-figure jury award.
Narrowing claims to one industry did not move them outside the abstract idea category.
A unanimous ruling on what a patent holder must allege when a generic label carves out the patented use.
In Recor Medical v. Medtronic Ireland, the Federal Circuit reversed a dismissal of patent infringement counterclaims and held that Medtronic Ireland's retained rights preserved its Article III standing.
